APITD1 抗体 (AA 48-74)
Our Local Distributor
北京 101111
Quick Overview for APITD1 抗体 (AA 48-74) (ABIN5536791)
抗原
See all APITD1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 48-74
-
纯化方法
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
免疫原
- This APITD1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 48-74 amino acids from the Central region of human APITD1.
-
亚型
- Ig Fraction
-
-
-
-
应用备注
-
For WB starting dilution is: 1:1000
For IHC-P starting dilution is: 1:50~100
For FACS starting dilution is: 1:10~50 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 0.5 mg/mL
-
缓冲液
- Supplied in PBS with 0.09 % (W/V) sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- APITD1 (Apoptosis-Inducing, TAF9-Like Domain 1 (APITD1))
-
别名
- APITD1
-
背景
- APITD1 was identified in the neuroblastoma tumour suppressor candidate region on chromosome 1p36. It contains a TFIID-31 domain, similar to that found in TATA box-binding protein-associated factor, TAF(II)31, which is required for p53-mediated transcription activation. This gene was expressed at very low levels in neuroblastoma tumours, and was shown to reduce cell growth in neuroblastoma cells, suggesting that it may have a role in a cell death pathway.
-
分子量
- 16 kDa
-
基因ID
- 100526739, 378708
-
UniProt
- Q8N2Z9
抗原
-